Auris Surgical reels in $280m in stealthy Series D round

Auris Surgical Robotics has stealthily raised a massive $280 million in a Series D round of financing, according to the company’s website and an SEC filing posted today. Money in the round came from 39 investors, led by newly invested Coatue Management and joined by Mithril, Lux Capital and Highland Capital Partners, according to the filing and the company’s website. The company is looking to raise an additional $4.9 million before closing the round, with the 1st sale recorded on April 5, according to the SEC filing. Auris Surgical is developing a robotic platform with an initial focus on lung cancer, having won FDA clearance for an Ares robot-assisted bronchoscopy platform last June. The company claims the platform “integrates the latest advancements in robotics, micro-instrumentation, sensing, and data science to achieve these breakthroughs and deliver dramatically improved clinical outcomes for patients,” according to its website. The company, co-founded by medical robotics pioneer Dr. Frederic Moll, turned heads when it bought Hansen Medical, which Moll co-founded, for $80 million last April. Moll has been an important factor in multiple startups in medical devices, and specifically robotics, including market leader Intuitive Surgical (NSDQ:ISRG), Mako Surgical, acquired in 2013 for $1.7 billion by Stryker(NYSE:SYK) and Restoration Robotics and its Artas hair restoration platform. Auris revealed in a September 2015 regulatory filing that...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Robot-Assisted Surgery Robotics Auris Surgical Robotics Source Type: news